GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
CHALFONT ST. GILES, England--(BUSINESS WIRE)--Sep 4, 2012--GE Healthcare, the healthcare business of GE (NYSE: GE), today introduced KUBio TM, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money. KUBio’s pre-made modules, which are assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility, are significantly faster to install than constructing a traditional factory. The modules are equipped with GE Healthcare’s world-class technologies for the start-to-finish manufacture of biopharmaceuticals.
GE Healthcare's KUBio (Graphic: Business Wire) Worldwide demand for biopharmaceuticals - such as antibodies for the treatment of cancer and rheumatoid arthritis, as well as the new generation of innovative vaccines - is increasing dramatically, driven by the global ageing population, rising obesity levels and the global effort to reduce the incidence of vaccine preventable diseases. KUBio will help manufacturers to respond to local healthcare needs and bring these potentially life-saving treatments to market more quickly.
KUBio is a fully functional off-the-shelf bioprocessing facility specifically designed to meet cGMP requirements while optimizing manufacturing flexibility and productivity. The 1200m 2 facility is pre-fabricated and delivered with a complete ready-to-use production line, based on GE Healthcare’s Ready-to-Process TM single-use technologies. With a total planning, delivery and construction time of 14-18 months, compared to the traditional 24 -36 months, both time-to-market and level of capital investment are significantly reduced. The first modular facilities to be introduced will be configured for the manufacture of monoclonal antibodies. GE Healthcare also plans to introduce modules for the manufacture of other biopharmaceuticals.
“KUBio is a totally new approach to the manufacture of biopharmaceuticals, bringing our customers a greatly simplified way to build their production capacity,” said Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences. “With KUBio our customers will be able to cut months off the typical construction time, and greatly streamline the whole construction process. We’re already seeing interest from a wide range of customers, from governments wanting to develop in-country manufacturing capability right through to pharmaceutical companies wanting to expand production capacity in new locations. KUBio is an industry game-changer that will help them do just that.” The introduction of KUBio expands GE Healthcare’s broad offering of world-class tools, technologies and services for the biopharmaceutical manufacturing industry, allowing customers to benefit from a wide range of solutions that can be tailored to meet specific needs, from pilot to commercial scale. GE Healthcare’s start-to-finish technologies and services include Fast Trak training, PAA cell culture media, ReadyToProcess single use technologies, specialist purification media and Xcellerex biomanufacturing systems. KUBio aligns with GE’s healthymagination initiative which focuses on reducing cost, increasing access and improving quality in healthcare.
About GE Healthcare GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394917&lang=enCONTACT: Media: GE Healthcare Dr Val Jones Global Media Relations Manager T +44 7917 175 192 Eval.email@example.com KEYWORD: UNITED KINGDOM UNITED STATES EUROPE NORTH AMERICA NEW YORK INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL MANUFACTURING OTHER MANUFACTURING CONSTRUCTION & PROPERTY OTHER CONSTRUCTION & PROPERTY GENERAL HEALTH MANAGED CARE SOURCE: GE Healthcare Copyright Business Wire 2012 PUB: 09/04/2012 04:30 AM/DISC: 09/04/2012 04:30 AM http://www.businesswire.com/news/home/20120904005723/